Skip to content

The effectiveness of esketamine-propofol mixture (esketofol) in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP)

The effectiveness of esketamine-propofol mixture (esketofol) in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200067201
Enrollment
Unknown
Registered
2022-12-29
Start date
2023-05-05
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the biliary tract and pancreas

Interventions

control group:Propofol combined with fentanyl anesthesia
experimental group:Anesthesia with propofol and esketamine

Sponsors

Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing ERCP; 2. Aged 18 ~ 80 years; 3. ASA I-III; 4. BMI:18~30kg/m^2.

Exclusion criteria

Exclusion criteria: 1. Patients with heart disease, severe hypertension, severe pulmonary dysfunction and hyperthyroidism; 2. Patients with mental or nervous system diseases; 3. Patients with severe liver and kidney insufficiency; 4. Severe hearing or visual impairment, unable to cooperate with patients; 5. Patients with contraindications to drugs; 6. Patients with drug allergies.

Design outcomes

Primary

MeasureTime frame
Vital signs indicators;

Secondary

MeasureTime frame
Incidence of intraoperative body movement;Patient recovery time;Patient recovery Steward score;Patients' satisfaction degree;Incidence of postoperative delirium;Incidence of postoperative nausea and vomiting;

Countries

China

Contacts

Public ContactGu Xiaoping

Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School

xiaopinggul@gmail.com+86 13813996903

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026